|
The document is an Analytical Phase Report for a reproduction study on PFOS conducted by 3M Environmental Laboratory, which outlines compliance with TSCA GLP standards and includes quality assurance statements regarding the study's methodology and data handling.
|
2002 |
AR226-1781
|
jZZeB6B7zo3mEq4Q4BJexrvO |
216 |
|
The document is an analytical phase report for a reproduction study on PFOS conducted with the Northern Bobwhite by 3M Environmental Laboratory, detailing compliance with TSCA GLP standards and noting certain exceptions.
|
2002 |
AR226-1781
|
red6bkmpmLKG2Kn54eLd4oavV |
226 |
|
3M submitted additional data to the EPA regarding a two-generation reproduction study on ammonium perfluorooctanoate, focusing on the effects of gestational age and body weight on reproductive outcomes in rats.
|
2002 |
AR226-1781
|
RaEkmxzZrBv7V1LDpVLJ9VJoE |
1 |
|
3M submitted a TSCA section 8(e) substantial risk notice to the EPA regarding findings from a toxicity study on perfluorohexane sulfonate potassium salt (PFHS), indicating adverse effects in parental male rats, including increased liver weight and thyroid changes, while no effects were observed in parental females.
|
2002 |
AR226-1138
|
2JME5E5oy11QrZKVVwOQMgRN |
2 |
|
3M submitted a TSCA Section 8(e) substantial risk notice to the EPA regarding findings from a toxicity study on perfluorohexane sulfonate potassium salt (PFHS), indicating adverse effects in parental male rats, including increased liver weight and thyroid cell changes, while no effects were observed in parental females.
|
2002 |
AR226-1781
|
reQorbXEw330jpO4aDnJ6YG8J |
2 |
|
3M submitted raw estrous cycling data and analyses related to ammonium perfluorooctanoate (PFOA) to the EPA as part of their ongoing dialogue regarding fluorochemicals, following a meeting on August 30, 2002, where toxicology studies were discussed.
|
2002 |
AR226-1781
|
da26RoE9nO0kNw1KvdXVb6eRR |
3 |
|
The document is a correspondence from Jo Ann Frazee at Argus Research to Dr. John Butenhoff at 3M, providing estrous cycle evaluation data for a two-generation reproduction study of Ammonium Perfluorooctanoate (APFO) in rats.
|
2002 |
AR226-1781
|
g2NKV7Nkzvodz77DB72qr345Q |
43 |
|
This document presents estrous cycling and litter observation data for rats exposed to varying doses of ammonium perfluorooctanoate (APFO), detailing cycle lengths, incidence of aberrant cycles, and reproductive outcomes such as implantations, liveborn, and stillborn counts across different dose groups.
|
2002 |
AR226-1781
|
nkvB7Be4ymnvE9je3OXZxR3ow |
2 |
|
This document is a final report revision from 3M detailing a study (T-6316.9) on the levels of PFOS in naive rats, aimed at identifying potential sources of contamination contributing to low-level PFOS body burdens found in control rats during dietary studies.
|
2002 |
AR226-1527
|
VJ5mL5eBoJxZexdG6J85Be3Y4 |
23 |
|
The document reports on an acute inhalation toxicity study of perfluoroctanesulfonyl fluoride (POSF) conducted by 3M, which found that rats exposed to 1000 ppm of POSF for 4 hours showed no significant adverse effects and had measurable levels of perfluorooctane sulfonate (PFOS) in urine and serum.
|
2001 |
AR226-1781
|
O3n5RM9zqLQZpDJOOgoJzy651 |
18 |
|
This document details the analytical method validation for the determination of perfluorooctanesulfonate (PFOS) in artificial soil, conducted by Wildlife International, Ltd. for 3M Corporation, and completed in compliance with Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
RJyjMZ6y8vg04e7V9eVwD0xbX |
46 |
|
This final report details a toxicity test conducted by Wildlife International, Ltd. for 3M Corporation to assess the effects of PFOS on the seedling emergence of seven plant species, completed in compliance with Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
jgKKNKr6zKKd86yjnDwEm4Nxk |
136 |
|
This document details the analytical method validation for determining perfluorooctanesulfonate (PFOS) in plant tissues, conducted by Wildlife International, Ltd. for 3M Corporation, and completed in compliance with Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
mBgMn324q9kw5p19ZxbJ6adGB |
51 |
|
A monitoring study conducted by Entrix, Inc. for 3M assessed the concentrations of selected fluorochemicals, including PFOS and PFOA, in surface water, sediments, clams, and fish near the 3M facility in Decatur, Alabama, revealing significant PFOS levels at the facility's outfall but no statistically significant changes in water quality downstream.
|
2001 |
AR226-1781
|
0LknVb1ddg5oakZENdXqndGvR |
40 |
|
The document is a final summary report of an extended recovery study on Perfluorooctane Sulfonic Acid Potassium Salt (PFOS) conducted in Cynomolgus monkeys, sponsored by 3M and compliant with EPA Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
zQxEMJjv9099ekoo61YJyZBo7 |
23 |
|
This document is a final report on an acute toxicity study of PFOS conducted with earthworms in an artificial soil substrate, submitted to 3M by Wildlife International, Ltd., and compliant with Good Laboratory Practice standards.
|
2001 |
AR226-1781
|
B5kLOJX7wkZ8324E0d00E5Q6o |
52 |
|
This document details a bioconcentration study of perfluorooctanesulfonate (PFOS) conducted using bluegill fish, produced by 3M, which assessed the substance's uptake and depuration under specific test conditions, revealing a purity of 86.9% and various exposure concentrations.
|
2001 |
AR226-1781
|
RpEb8wQwdv91X6ppQXpwZD74a |
5 |
|
The document details a revised soil adsorption study for Perfluorooctanesulfonate (PFOS), including its purity, testing methods based on OECD guidelines, and soil characteristics from various sources in Minnesota and North Dakota.
|
2001 |
AR226-1781
|
ppRe4pBQ8p6kQ7gBDv28LrDJX |
4 |
|
The document is a final report from 3M Company detailing a cross-sectional analysis of serum levels of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) among employees participating in the 2000 medical surveillance program at their Antwerp and Decatur fluorochemical manufacturing plants, highlighting the demographics and participation rates of the employees involved.
|
2001 |
AR226-1781
|
0QeRDJGEBEXEny7qb2obM91R |
122 |
|
The document is a final report from 3M Company detailing a longitudinal analysis of serum levels of Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) in relation to lipid and hepatic clinical chemistry test results among male employees participating in the company's fluorochemical medical surveillance program conducted in 1994/95, 1997, and
|
2001 |
AR226-1781
|
pBdZ5q0GawkVoQoYJXLwOJNwa |
63 |
|
The document reports on an acute inhalation toxicokinetic study of perfluoroctanesulfonyl fluoride (POSF) conducted by 3M, which found that a small percentage of inhaled POSF was converted to perfluorooctanesulfonate (PFOS) in the serum of rats, with no significant adverse effects observed.
|
2001 |
AR226-1781
|
ZBje3Zm2ZRG7z1ENyk7G5V6q8 |
18 |
|
The document details a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on mallards, revealing overt signs of toxicity at higher concentrations, leading to the termination of the 150 ppm and 50 ppm treatment groups due to health concerns.
|
2001 |
AR226-1781
|
9J5p2KbbkbJQyEerZvmepBXpV |
11 |
|
The document reports on a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services, focusing on the extraction of potassium perfluorooctanesulfonate (PFOS) from egg components using HPLC-Electrospray/Mass Spectrometry, and confirms compliance with Good Laboratory Practice standards with noted exceptions.
|
2001 |
AR226-1781
|
03pvN9dyB7X4qdjMyKjqXVrO |
102 |
|
The document is a final report on a reproduction study conducted by Wildlife International, Ltd. for 3M Corporation, assessing the effects of PFOS on mallards, completed on August 21, 2003, and compliant with Good Laboratory Practice standards.
|
2001 |
AR226-1781
|
kJdM4m8nMX89djLxjareRyNy |
203 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of Potassium Perfluorooctanesulfonate from mallard serum and liver using HPLC-Electrospray/Mass Spectrometry, ensuring compliance with US EPA TSCA Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
aJnYg6ER0oQ7wYrpXN1p6Qpze |
104 |
|
This laboratory report details a PFOS dietary LC50 study conducted by 3M Environmental Technology & Safety Services on northern bobwhite birds, revealing significant variability in PFOS levels in sera among individual animals while liver levels showed more consistency, with both tissue types generally increasing with dose level.
|
2001 |
AR226-1781
|
pm37MYkLMr4qgyR3oydX19Nv6 |
16 |
|
The document presents a toxicological summary of a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on Northern bobwhite quail, detailing the experimental design, treatment levels, and observations of toxicity, particularly noting that high doses (150 ppm and 50 ppm) resulted in overt signs of toxicity and were terminated early.
|
2001 |
AR226-1781
|
Ra2jeB0B2zmoBg88q4LDMbw5k |
11 |
|
The document is a final report on a reproduction study of PFOS (perfluorooctanesulfonic acid) conducted on the Northern Bobwhite, sponsored by 3M Corporation and compliant with Good Laboratory Practice Standards, detailing the study's initiation and completion dates along with the protocols used.
|
2001 |
AR226-1781
|
n6958xeGj4v8ym7xae1Nwd21 |
196 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from quail serum and liver using HPLC-Electrospray/Mass Spectrometry, which was performed in compliance with US EPA TSCA Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
MRQnN35YNLMEjxX8zpXgRye7 |
102 |
|
The document is a final report detailing a pharmacokinetic study of potassium perfluorooctanoate (PFOA) in cynomolgus monkeys, conducted by Southern Research Institute for 3M Corporation, which found that the terminal half-life of PFOA in serum varied between male and female monkeys, with concentrations declining over time but remaining detectable for an extended period.
|
2000 |
AR226-1781
|
DGzzVxE5EnaE1DEjQJDr5MaZa |
60 |
|
The document reports on a study conducted by Southern Research Institute to determine the percent protein binding of perfluorohexane sulfonate, perfluorooctane sulfonate, and perfluorooctanoate in human, rat, and monkey plasma, as well as various human-derived plasma protein fractions.
|
2000 |
AR226-1781
|
b5GdBBdrX7baRpmeapLREKOq6 |
47 |
|
This is a report amendment from Argus Research Laboratories regarding a fertility and developmental toxicity study of N-EtFOSE in rats, correcting Text Figure 1 without affecting the study results.
|
2000 |
AR226-1781
|
n95XOb34BvNnYN9qeLjao387m |
2 |
|
The document details a laboratory-scale study on the thermal degradation of perfluorooctanesulfonate (PFOS) and related substances, specifically evaluating the potential environmental sources of PFOS from thermal degradation of fluorochemical compounds FC-807A and FC-1395.
|
2000 |
AR226-1781
|
xjdyaYoD74wm127qq5eyn0Gam |
13 |
|
This final report details a flow-through bioconcentration test of Perfluorooctanesulfonate (PFOS) using bluegill fish (Lepomis macrochirus), conducted by Wildlife International, Ltd. for 3M Corporation, in compliance with EPA Good Laboratory Practice Standards.
|
2000 |
AR226-1781
|
dD2XL6bnZNnoL4KvXxmmX0Ko9 |
134 |
|
The document is an amended final report of a soil adsorption/desorption study of potassium perfluorooctanesulfonate (PFOS) conducted by 3M Environmental Laboratory, initiated on October 17, 2000, and compliant with TSCA Good Laboratory Practice standards.
|
2000 |
AR226-1781
|
zo5oJ8XMjBoqv1qrNqRy1Rxjm |
24 |
|
This is a cover page from Pace Analytical Services, Inc. for the 3M Multi-city Food Study, prepared under contract with 3M, with project number 1039292.
|
2000 |
AR226-1781
|
LVKaRoGYEzvLEEZv08ygrm4q |
1 |
|
The document is a correspondence from Wildlife International, Ltd. to 3M Corporation, providing addendums for studies on the solubility of PFOS in various mediums.
|
2000 |
AR226-1781
|
mqyQJxkXQpo3jGa2QELXnE1ZJ |
1 |
|
The document is an addendum for a study on PFOS conducted by Wildlife International, Ltd., specifically detailing an Activated Sludge, Respiration Inhibition Test for 3M Corporation.
|
2000 |
AR226-1781
|
kZjQD5Yag9vekEzb8J5eNZ1O |
1 |
|
This is a letter from Wildlife International, Ltd. to 3M Corporation transmitting addendums for multiple project numbers related to ecotoxicology testing.
|
2000 |
AR226-1781
|
gnELGZ0XLdkLq88Qam5J8ypG |
1 |
|
The document is the final report of study T-6295.28, which analyzes liver enzymes, glycogen levels, and PFOS concentration in liver samples from rats treated with varying doses of PFOS, sponsored by 3M Specialty Chemicals Division.
|
2000 |
AR226-1781
|
KG2M3nzz5pNkB4BQr8V4V8aEX |
13 |
|
The document is a final report from Boston University detailing a study on the activation of peroxisome proliferator-activated receptors (PPARs) by perfluorooctanesulfonate (PFOS), finding that PFOS activates both PPARa and PPARy, with implications for lipid metabolism and potential health effects.
|
2000 |
AR226-1781
|
gXQNkr2ypKmmMQQjapbaMb0L |
55 |
|
This document provides a toxicological summary of a dietary acute study on perfluorooctanesulfonate (PFOS) conducted on mallards, detailing the test substance's purity, methodology, and experimental design, including exposure and recovery periods.
|
2000 |
AR226-1781
|
ExmYX19gpL5VdrrEkwpEq6Jax |
11 |
|
The document is a final report on a pilot reproduction study of PFOS conducted on mallards by Wildlife International, Ltd. for 3M Corporation, completed on December 18, 2003, in compliance with Good Laboratory Practice standards.
|
2000 |
AR226-1781
|
DM48Z7vMGjOZ51p4JxaxaYYgN |
125 |
|
The document summarizes a dietary chronic pilot reproductive study on the effects of perfluorooctanesulfonate (PFOS) on adult mallards, detailing the experimental design, exposure concentrations, and evaluation of health and reproductive outcomes over a 20-week period.
|
2000 |
AR226-1781
|
8RE0E72zymNoXM7ZN8RyGeJoa |
12 |
|
This document summarizes a dietary acute toxicity study of perfluorooctanesulfonate (PFOS) conducted on Northern Bobwhite quail, detailing changes in the purity of the test substance and the methodology used in the study.
|
2000 |
AR226-1781
|
DnMxom60mkKa9X3OBdVew7qN |
11 |
|
The document is a final report on a pilot reproduction study of PFOS conducted on the Northern Bobwhite, submitted by Wildlife International, Ltd. to 3M Corporation, and completed in compliance with Good Laboratory Practice Standards.
|
2000 |
AR226-1781
|
zzNgMB3wz6eyLo9RB6mYjkd3B |
125 |
|
The document summarizes a dietary chronic pilot reproductive study on perfluorooctanesulfonate (PFOS) conducted on Northern Bobwhite quail, detailing exposure levels, methods, and the evaluation of health effects and reproductive outcomes over a 20-week period.
|
2000 |
AR226-1781
|
Yjwwve4Mx0g6n0ogp89ZbryMK |
12 |
|
This document reports on a dietary LC50 study of PFOS conducted by Wildlife International Ltd. for 3M Corporation, which was completed on April 26, 2000, and amended on March 23, 2004, noting compliance with Good Laboratory Practice standards despite some exceptions regarding test substance characterization.
|
1999 |
AR226-1781
|
gbY3vO3wKMok0399mKg7B1YVV |
72 |
|
This document details a dietary LC50 study of PFOS conducted on the Northern Bobwhite by Wildlife International Ltd. for 3M Corporation, indicating compliance with Good Laboratory Practice standards and noting that the test substance was recharacterized post-study.
|
1999 |
AR226-1781
|
kyOxnGRJvnB7o9wDEN7av8G0 |
69 |
|
This document details a two-generation reproduction study of ammonium perfluorooctanoate (APFO) in rats, conducted by Argus Research under EPA guidelines, with noted exceptions to Good Laboratory Practice compliance regarding the analytical portion of the study.
|
1998 |
AR226-1781
|
5LM2L99bymM2J6xM9v9kLJNY8 |
1245 |
|
This letter from the Department of Health and Human Services addresses a Health Hazard Evaluation regarding employee exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) at the 3M Corporation in Cottage Grove, Minnesota, finding no noted health effects despite concerns over elevated blood fluoride levels among workers.
|
1998 |
AR226-1781
|
ZwvgRxZeGGXzpGMmv8MkddV8 |
6 |
|
The document details a study conducted by Exygen Research for 3M Environmental Laboratory, analyzing pooled human and monkey sera for fluorocarbons, specifically noting compliance with OECD Good Laboratory Practice standards while highlighting several exceptions regarding data management and test item stability.
|
1997 |
AR226-1781
|
N27Nvzk9VrNoGebMxzY8kxawp |
111 |
|
The document details an acute toxicity test of perfluorooctanesulfonate (PFOS) on bluegill sunfish (Lepomis macrochirus) conducted in 1978, using a static method over a 96-hour exposure period with various water chemistry parameters monitored.
|
1978 |
AR226-1781
|
jyEbjBJXjm4y5z4o5EBQDOLop |
1 |
|
The document reports on a study conducted by 3M to investigate the mechanism of toxicity in adult rats exposed to high levels of Perfluorooctanesulfonate (PFOS), specifically examining its potential to damage muscle mitochondria and lead to conditions like rhabdomyolysis and lactic acidosis.
|
1962 |
AR226-1781
|
jJyxDK8kbzpjmw2BXbYx51v9 |
14 |
|
The document discusses the covariant analysis for study 418-020 related to sexual maturation in rats exposed to a test substance, with a focus on how gestational age and body weight affect maturation outcomes, potentially relevant for understanding the effects of PFOA or PFOS.
|
1962 |
AR226-1781
|
6w4bE9nXz0OEEN0mgVV6qxRa3 |
22 |
|
This laboratory report from 3M Environmental Technology & Safety Services details a PFOS dietary LC50 study conducted on mallard ducks, revealing that PFOS levels in the sera and livers increased with dosage but declined significantly between days 8 and 22 post-exposure.
|
1902 |
AR226-1781
|
rex7w6mZm6oozdxgeQ9a2jQq7 |
14 |
|
The document is an analytical report from 3M Environmental Laboratory detailing a comparative analysis of fluorochemicals, including PFOA and PFOS, in human serum samples obtained commercially, with a study completion date of November 13, 2002.
|
— |
AR226-1781
|
dQ4NjqQzkjOob1GvaYrMO4qNG |
52 |
|
The document is a report from Northwest Bioanalytical detailing the assay validation for the quantitative determination of PFOS and its metabolites in human serum, prepared for 3M Environmental Technology and Services.
|
— |
AR226-1781
|
997MKbRKGGrQ8vBb96LpyQ0DR |
135 |
|
This document is an assay validation report from Northwest Bioanalytical for the quantitative determination of PFOS, PFOSA, PFOSAA, POAA, PFHS, M556, and M570 in human serum, prepared for 3M Environmental Technology and Services.
|
— |
AR226-1781
|
mmbx3eg1xj6xZRXBkd5bMd2kd |
103 |
|
This document is an assay validation report from Northwest Bioanalytical for the quantitative determination of PFOS and related compounds in human serum, prepared for 3M.
|
— |
AR226-1781
|
0gkmg5aBDKX5QEB0ML6Yk4GdO |
98 |
|
This document is a sample analysis report from Northwest Bioanalytical for the quantitative determination of PFOS and related compounds in human serum, prepared for 3M Company under study protocol EPI-0011.
|
— |
AR226-1781
|
qo8EDOvNKyp5490QLXRXvnvG |
124 |
|
This document is a sample analysis report from Northwest Bioanalytical for the quantitative determination of PFOS and related compounds in human serum, prepared for 3M Company under study protocol EPI-0013.
|
— |
AR226-1781
|
2jODejYJJrZEqZ827nL93pDLp |
136 |
|
This document is a quantitative analysis report prepared by Northwest Bioanalytical for 3M Company, detailing the determination of PFOS and related compounds in human serum using LC/MS/MS under study protocol EPI-0016.
|
— |
AR226-1781
|
KzKzGxB2ODKw7Gr8104R23KKN |
76 |
|
This document reports on a study conducted by 3M to investigate the effects of PFOS exposure during gestation on perinatal mortality and respiratory function in rat pups, including the analysis of PFOS levels in amniotic fluid.
|
— |
AR226-1781
|
e7bmrz547ZKm1RXMBLk7Bjnk9 |
21 |
|
This document is an analytical laboratory report from a 26-week toxicity study conducted by 3M on Perfluorooctanesulfonic Acid Potassium Salt (PFOS) in Cynomolgus monkeys, detailing the determination of PFOS presence and concentration in liver and serum samples, while noting compliance with EPA Good Laboratory Practice standards.
|
— |
AR226-1070
|
dnovwGg1vQqJn4vd6XpNa3nye |
232 |
|
This document reports on a 104-week dietary chronic toxicity study of Perfluorooctane Sulfonic Acid Potassium Salt (PFOS T-6295) in rats, conducted by 3M Environmental Laboratory, focusing on the determination of PFOS concentrations in liver and serum specimens.
|
— |
AR226-1070
|
aB6X6oJKRa2Kg3JXY50OobpzN |
181 |
|
This document is an addendum to a study conducted by Wildlife International Ltd. on the acute toxicity of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) to the saltwater mysid (Mysidopsis bahia), which includes revised results based on a purity adjustment from 90.49% to 86.9%.
|
— |
AR226-1781
|
v6X9Q9roj4JRVOO1qp4b8xRRw |
7 |
|
This document reports on a non-GLP study conducted by Wildlife International, Ltd. for 3M Corporation, determining the solubility of PFOS in freshwater, freshwater algal medium, and saltwater, with mean solubility concentrations of 326 mg/L, 378 mg/L, and a value not fully provided, respectively.
|
— |
AR226-1781
|
dYQo39ZNmexprb6dje6Dm1eMQ |
6 |
|
This document reports on an activated sludge respiration inhibition test for PFOS conducted by Wildlife International, Ltd., detailing a revision of results based on a purity adjustment from 90.49% to 86.9%, and describes the methodology and findings related to the effect of PFOS on activated sludge microorganisms.
|
— |
AR226-1781
|
77qmbMkXnzzNd2j0nMw0LywR |
6 |
|
This document is an addendum to a 96-hour static acute toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) conducted by Wildlife International Ltd. for 3M Corporation, which includes a revision of results based on a purity change from 90.49% to 86.9%.
|
— |
AR226-1781
|
By5ZJjJ7worKmmMxENG193KRL |
7 |
|
This document is an addendum to a study by Wildlife International Ltd. on the water solubility of PFOS, indicating a revision of the test substance's purity from 98.9% to 86.9%, which resulted in a corrected mean solubility concentration of PFOS in NANOpure water of 498 mg a.i./L.
|
— |
AR226-1781
|
ZJLkD19N5jyY1nJJBm7p4m2EJ |
6 |
|
This document is an addendum to a 96-hour toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) conducted by Wildlife International Ltd. for 3M Corporation, which includes a revision of results based on a purity analysis adjustment from 90.49% to 86.9%.
|
— |
AR226-1781
|
2XzDYZ6RQ2dgp8ywLb4oZokr |
8 |
|
This document is an addendum to a study by Wildlife International, Ltd. on the acute toxicity of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) to the cladoceran Daphnia magna, which includes revised results based on a purity adjustment from 90.49% to 86.9%.
|
— |
AR226-1781
|
6wOZMMwBKkwYXzq5o0XRn6KxE |
7 |
|
This document is an addendum to a study conducted by Wildlife International, Ltd. on the acute toxicity of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) to the freshwater mussel (Unio complamatus), which includes a revision of test results based on updated purity analyses from 90.49% to 86.9%.
|
— |
AR226-1781
|
XRnzgxq74j9wXR9KBN37yZvrw |
7 |
|
This document is an addendum to a study by Wildlife International, Ltd. on PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) that details a 96-hour shell deposition test with the Eastern Oyster (Crassostrea virginica), including a revision of test results based on updated purity analysis from 90.49% to 86.9%.
|
— |
AR226-1781
|
Gq6LNzVqv6J2ErZvX6jJ77q4 |
7 |
|
This document is an addendum to a toxicity test report conducted by Wildlife International, Ltd. for 3M Corporation, detailing a flow-through life-cycle toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) on the saltwater mysid (Mysidopsis bahia), which includes a revision of test results based on updated purity analysis from 90.
|
— |
AR226-1781
|
nk01MRGo9Xj2Lo9owGgr9Epb6 |
7 |
|
This document is an addendum to a toxicity test report conducted by Wildlife International Ltd. for 3M Corporation, detailing the early life-stage toxicity of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) on fathead minnows, including a revision of results based on a purity adjustment from 90.49% to 86.9%.
|
— |
AR226-1781
|
wqe97bwQn4Rmb2LKvNzwKEOaE |
7 |
|
This document is an addendum to a study by Wildlife International, Ltd. on the toxicity of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) to the cladoceran Daphnia magna, which includes a revision of results based on a purity adjustment from 90.49% to 86.9% as requested by the sponsor, 3M Corporation.
|
— |
AR226-1781
|
wrp3VZy9xMDgqo5R8vq062R1V |
7 |
|
This is an aquatic toxicity data sheet detailing a test conducted by the Environmental Engineering Laboratory, which includes information on the test organisms, conditions, and results over various time intervals.
|
— |
AR226-1781
|
bZD1Q5m2EbMpE2aXQo142OMO |
1 |
|
The document reports that a Covance study found that perfluorooctane sulfonic acid (PFOS) does not interfere with the serum cholesterol assay used in their testing.
|
— |
AR226-1781
|
vBxL1O4nq3LEKvom5LJxgjnYq |
2 |
|
The document details a study conducted by 3M to assess the oral toxicity of perfluorooctanesulfonyl fluoride (POSF) in rats, focusing on preliminary toxicity data following single oral exposure at varying dose levels.
|
— |
AR226-1781
|
7OJ9vkQmnmzanzyzakJJb2NJa |
7 |
|
The document is a sample analysis report from Northwest Bioanalytical for 3M, detailing the quantitative determination of PFOS and related compounds in human serum using LC/MS/MS under study protocol EPI-Swed.
|
— |
AR226-1781
|
062xm2V3287mpR628wgXN4YvV |
24 |
|
This document is a sample analysis report from Northwest Bioanalytical for the quantitative determination of PFOS and related compounds in human serum and plasma, prepared for the 3M Company under study protocol EPI-0012.
|
— |
AR226-1781
|
ZJn1EpZpnXMKD36YrMwGE4wVZ |
90 |
|
The document presents ecotoxicological testing results for PFOS, comparing effect concentrations calculated using different sample purities, highlighting various no-observed effect concentrations (NOEC) and effective concentrations (EC) across multiple aquatic and avian species.
|
— |
AR226-1781
|
Ra29YXe7O2roMGXEKzRE74O8V |
1 |
|
The document is a sample analysis report from Northwest Bioanalytical for 3M, detailing the quantitative determination of PFOS and related compounds in human serum using LC/MS/MS, conducted under study protocol EPI-PEuro.
|
— |
AR226-1781
|
0JJJ8wQJZrB6Qw1xDBYzrzYgb |
23 |
|
This analytical report by Exygen Research, requested by 3M Environmental Technology and Safety Services, details the total perfluorooctanesulfonate (PFOS) content found in mallard and quail egg yolk samples, including the distribution of PFOS in different yolk fractions.
|
— |
AR226-1781
|
nRDbxZmBEXXrjVYEwxGOBX4R |
64 |
|
This document contains estrous cycle data for multiple groups of animals in the P1 generation, detailing the number of days in estrus, diestrus, and proestrus, as well as mean cycle lengths and the number of cycles observed.
|
— |
AR226-1781
|
zbMx5Xno781XJVkpr4Ek7eeX6 |
18 |
|
This document is a notice from 3M regarding the submission of information to the EPA about fluorochemistry, emphasizing the importance of maintaining the integrity of the documents provided.
|
— |
AR226-1781
|
YDdbK4xzOKO5e0DrjVD9jamkD |
1 |